Diagnostics
Eliminate
Malaria
Our commitment
At Zendia GmbH we are committed to develop innovative diagnostic technologies for infectious diseases and cell analysis capable of transforming healthcare outcomes for people worldwide.
A RAPID AND ACCURATE DIAGNOSIS ALLOWS EARLY TREATMENT AND SAVES LIFES
EXTREME SENSITIVITY
ACHIEVED BY A CELL
ENRICHMENT TECHNOLOGY
Our Focus
We are focussed on InfectoTest® platform: an unique and extremely sensitive diagnostic system at the Point-of-Care.
InfectoTest® is the only diagnostic system available with a cell enrichment process and single cell detection.
Diagnostic Challenge
• Malaria is a real scourge of humanity causing 247 million symptomatic cases and 720 000 deaths every year, especially at small children.
• Additional 1.2 billions of asymptomatic carriers can not be detected.
• Malaria is preventable and curable if diagnosed on time. However, different limitations hamper malaria diagnosis at the Point-of-Care.
MALARIA NEEDS INNOVATIVE DIAGNOSTICS
OUR BREAKTHROUGH DIAGNOSTICS: FAST, EASY, POINT-OF-CARE
Our Solution: InfectoTest®
InfectoTest® is a malaria diagnostic test with an exceptional sensitivity, 100 fold higher than RDTs and high specificity, which provides real time infectious status.
InfectoTest® is designed for use at the Point-of-Care with minimal medical infrastructure, making it accessible in low resource settings.
“Reliable and – most importantly – fast diagnostics are of the essence when it comes to infectious diseases, because all pathogens multiply exponentially in the patient´ s blood Zendia´s innovative rapid diagnosis platform enables an earlier and possibly lifesaving therapy I do believe this platform is an important development of medical technology.”
PROF. MANFRED EIGEN NOBEL PRIZE CHEMISTRY
